title: Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism.
abstract: Serotonin (5-HT) stimulates aldosterone secretion in man through 5-HT4 receptors positively coupled to adenylyl cyclase. In particular, it has been shown that oral administration of a single dose of the 5-HT4 receptor agonist cisapride induces a significant increase in plasma aldosterone levels (PAL) in healthy volunteers. Idiopathic hyperaldosteronism (IH) is a rare disorder characterized by hypertension, hypokalemia and bilateral adrenal hypersecretion of aldosterone. In patients with IH, administration of the 5-HT precursor 5-hydroxytryptophan (5-HTP) is followed by a significant increase in PAL. 5-HTP-induced aldosterone secretion has been attributed to the activation of central serotonergic pathways. The aim of the present study was to evaluate the effect of the oral administration of a single dose of cisapride (10 mg) on aldosterone secretion in 15 patients with IH, in a simple blind fashion versus placebo. Cisapride induced a significant increase in PAL but did not affect renin, cortisol and potassium levels. The present study demonstrates that 5-HT4 receptor agonists are able to stimulate aldosterone secretion in patients with IH. These data also indicate that hyperplastic glomerulosa tissue, like normal glomerulosa cells, expresses a functional 5-HT4 receptor. Therefore, 5-HT4 receptor antagonists may represent a new approach in the treatment of primary hyperaldosteronism.
authors.affiliation: European Institute for Peptide Research, Department of Endocrinology and Metabolic Diseases, Rouen, France.
authors.forename: H
authors.initials: H
authors.lastname: Lefebvre
authors.forename: D
authors.initials: D
authors.lastname: Cartier
authors.forename: C
authors.initials: C
authors.lastname: Duparc
authors.forename: V
authors.initials: V
authors.lastname: Contesse
authors.forename: I
authors.initials: I
authors.lastname: Lihrmann
authors.forename: C
authors.initials: C
authors.lastname: Delarue
authors.forename: H
authors.initials: H
authors.lastname: Vaudry
authors.forename: R
authors.initials: R
authors.lastname: Fischmeister
authors.forename: J M
authors.initials: JM
authors.lastname: Kuhn
mesh_terms: D000450:Aldosterone / Q000378:metabolism*; D020117:Cisapride / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000378:metabolism*; D008297:Male; D011985:Receptors, Serotonin / Q000378:metabolism*; D044422:Receptors, Serotonin, 5-HT4; D012083:Renin / Q000097:blood; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*
chemical_list: D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D044422:Receptors, Serotonin, 5-HT4; D000450:Aldosterone; D012083:Renin; D020117:Cisapride